Evaluation of routine CT scans in the follow-up of diffuse large B-cell lymphomas

References

• Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, et al. Global, regional, and National Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 Cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–548.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–2390.
   PubMed Web of Science ®Google Scholar
• Teras LR, DeSantis CE, Cerhan JR, et al. US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;2016(66):443–459.
   Google Scholar
• Liu Y, Barta SK. Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2019;94:604–616.
   PubMed Web of Science ®Google Scholar
• Christopher AMLS M. HHS public access. Physiol Behav. 2016;176:100–106.
   Google Scholar
• Al-Hamadani M, Habermann TM, Cerhan JR, et al. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer data base from 1998 to 2011. Am J Hematol. 2015;90:790–795.
   PubMed Web of Science ®Google Scholar
• Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea. Guía de GELTAMO para Tratamiento del linfoma B difuso de célula grande (LBDCG). SEHH. 2016.
   Google Scholar
• Jones SE, Grozea PN, Metz EN, et al. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma. A southwest oncology group study. Cancer. 1979;43:417–425.
   PubMed Web of Science ®Google Scholar
• Guppy AE, Tebbutt NC, Norman A, et al. The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin’s lymphoma. Leuk Lymphoma. 2003;44:123–125.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3068.
   PubMed Web of Science ®Google Scholar
• Kallam A, Adusumalli J, Mph M, et al. Surveillance in patients with diffuse large B cell lymphoma. Mayo Clin Proc. 2020;95:157–163.
   PubMed Web of Science ®Google Scholar
• Thompson CA, Ghesquieres H, Maurer MJ, et al. Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol. 2014;32:3506–3512.
   PubMed Web of Science ®Google Scholar
• Goldschmidt N, Or O, Klein M, et al. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Ann Hematol. 2011;90:165–171.
   PubMed Web of Science ®Google Scholar
• Kang KW, Lee SR, Kim DS, et al. Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma. PLoS One. 2018;13:1–14.
   Web of Science ®Google Scholar
• El-Galaly TC, Jakobsen LH, Hutchings M, et al. Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a danish–Swedish population-based study. J Clin Oncol. 2015;33:3993–3998.
   PubMed Web of Science ®Google Scholar
• Tilly H, da Silva M G, Vitolo U, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v116–v125.
   PubMed Web of Science ®Google Scholar
• Dixon JR Jr. The international conference on harmonization good clinical practice guideline. Qual Assur. 1999;6:65–74.
   Google Scholar
• Goldman ML, Mao JJ, Strouse CS, et al. Surveillance imaging during first remission in follicular lymphoma does not impact overall survival. Cancer. 2021;127:3390–3402.
   PubMed Web of Science ®Google Scholar
• Larouche JF, Berger F, Chassagne-Clément C, et al. Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome. J Clin Oncol. 2010;28:2094–2100.
   PubMed Web of Science ®Google Scholar
• Piercey OA, Loh Z, Chan J, et al. Routine blood tests in asymptomatic patients with indolent lymphoma have limited ability to detect clinically significant disease progression. JCO Oncol Pract. 2020;16:e1315–e1323.
   PubMedGoogle Scholar
• Hawkes EA, Loh Z, Estacio O, et al. Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission. Br J Cancer. 2018;119:546–550.
   PubMed Web of Science ®Google Scholar
• Giulino-Roth L, Pei Q, Buxton A, et al. Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the children’s oncology group. Blood. 2021;137:1449–1456.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Computed tomography – an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–2284.
   PubMed Web of Science ®Google Scholar
• Chien SH, Liu CJ, Hu YW, et al. Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: a nationwide population-based study. Int J Cancer. 2015;137:658–665.
   PubMed Web of Science ®Google Scholar
• Heimann P, Dewispelaere L. Indications of next-generation sequencing in non-hodgkin’s lymphoma. Curr Opin Oncol. 2020;32:391–397.
   PubMed Web of Science ®Google Scholar
• Galimberti S, Genuardi E, Mazziotta F, et al. The minimal residual disease in non-Hodgkin’s lymphomas: from the laboratory to the clinical practice front. Oncol. 2019;9:528.
   Google Scholar
• Thompson CA, Charlson ME, Schenkein E, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in longterm lymphoma survivors. Ann Oncol. 2010;21:2262–2266.
   PubMed Web of Science ®Google Scholar
• Huntington SF, Svoboda J, Doshi JA. Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission. J Clin Oncol. 2015;33:1467–1474.
   PubMed Web of Science ®Google Scholar